[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100378384":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":15,"locations":21,"responsibleParty":55,"collaborators":7,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":7,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":7,"enrollmentInfo":65,"targetDuration":68,"studyType":69,"phases":7,"briefSummary":70,"conditions":71,"keywords":7,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Chinese Pulmonary Vascular Disease Research Group","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"PROCEDURE","Balloon pulmonary angioplasty","Balloon pulmonary angioplasty is an interventional technique where a balloon catheter is used to recanalize affected segments of pulmonary arteries identified during angiography.",[14],"BPA",[16],{"name":17,"role":18,"phone":19,"phoneExt":7,"email":20},"Zhihong Liu, doctor","CONTACT","86-010-88396589","zhihongliufuwai@163.com",[22,41],{"facility":23,"status":24,"city":25,"state":7,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"center of pulmonary vascular disease, Fuwai hospital","RECRUITING","Beijing","100037","China","CN",{"type":30,"coordinates":31},"Point",[32,33],116.39723,39.9075,{"lat":33,"lon":32},[36,38],{"name":17,"role":18,"phone":37,"phoneExt":7,"email":20},"8601088396816",{"name":39,"role":40,"phone":7,"phoneExt":7,"email":7},"Zhihong Liu, MD,PhD","PRINCIPAL_INVESTIGATOR",{"facility":42,"status":24,"city":25,"state":7,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":43,"geoPoint":45,"contacts":46},"Chinese Academy of Medical Sciences Fuwai hospital",{"type":30,"coordinates":44},[32,33],{"lat":33,"lon":32},[47,51],{"name":48,"role":18,"phone":49,"phoneExt":7,"email":50},"Zhao zhihui, MD","8615810348817","1250167892@qq.com",{"name":52,"role":18,"phone":53,"phoneExt":7,"email":54},"Yang Tao, MD","8618610358576","tsmcyt@163.com",{"type":56,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100378384","safety-and-efficacy-of-balloon-pulmonary-angioplasty-in-china-100378384",false,"NCT04206852","Safety and Efficacy of Balloon Pulmonary Angioplasty in China","Inclusion Criteria:\n\n1. diagnosed with CTEPH according to ESC Guidelines (1) Mean PAP ≥ 25mmHg at rest; or if mean PAP \\\u003C 25mmHg at rest, have exercise limitations from chronic thromboembolic disease (2)Abnormal ventilation perfusion lung scanning (VQ) scan, pulmonary angiogram, computer tomographic pulmonary angiogram, or magnetic resonance pulmonary angiogram confirming chronic thromboembolic disease as recommended by standard guidelines\n2. Treatment with anticoagulation for ≥ 3 months before diagnosis of CTEPH\n3. Not amenable to pulmonary endarterectomy\n4. Willing to provide informed consent\n\nExclusion Criteria:\n\n1. Patients unwilling or unable to provide written consent for participation in the study.\n2. Impossible to follow up.","ALL","18 Years",{"count":66,"type":67},200,"ESTIMATED","4 Years","OBSERVATIONAL","Balloon pulmonary angioplasty (BPA) is a potential treatment for non-operable patients with chronic thromboembolic pulmonary hypertension (CTEPH).\n\nThe aim of this study was to evaluate the safety and efficacy of BPA in CTEPH patients not amenable to pulmonary endarterectomy(PEA) or suffered from persistent CTEPH after PEA.",[72],"Chronic Thromboembolic Pulmonary Hypertension","2023-12-14",{"date":75,"type":76},"2023-12-20","ACTUAL",{"date":78,"type":76},"2018-05-11",{"date":80,"type":67},"2028-05-11",{"name":5,"class":6},2]